483 Aurobindo Pharma (Unit III) Aug 2018

483 Aurobindo Pharma (Unit III) Aug 2018

Jennifer Adams FDA, Courtney Long FDA$119.00 - Available Now

FDA investigators audited the Aurobindo Pharma (Unit III) - Medchal, India facility and issued inspectional observations (via FDA 483) on 10 Aug 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 10 Aug 2018
  • Location: Medchal, India
  • FEI: 3004021229
Add To Cart